Evidence map›Paper›PMID 41055810›Full record

ArticleJournal of patient-reported outcomes2025

Clinical characteristics and quality of life for rhegmatogenous retinal detachment in a tertiary centre in Ghana: a case control study.

Akwasi Ahmed, Emmanuel Appiagyei, Jessica Sedhom, Arthur Brant, Andrew DesLauriers, Alec Bernard, Amos Aikins, Seth Lartey, Kwesi Amissah-Arthur

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of patient-reported outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akwasi AhmedEye Centre, Komfo Anokye Teaching Hospital, Kumasi, Ghana.ORCID http://orcid.org/0000-0001-9076-209X
Emmanuel AppiagyeiDepartment of Optometry and Visual Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. drappiagyei@hotmail.com.ORCID http://orcid.org/0000-0002-7207-6202
Jessica SedhomTulane University School of Medicine, New Orleans, LA, USA.
Arthur BrantByers Eye Institute, Stanford University, Palo Alto, CA, USA.
Andrew DesLauriersUniversity of Vermont School of Medicine, Burlington, VT, USA.
Alec BernardByers Eye Institute, Stanford University, Palo Alto, CA, USA.
Amos AikinsEye Centre, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Seth LarteyEye Centre, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Kwesi Amissah-ArthurEye Unit, Department of Surgery, Korle Bu Teaching Hospital, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the Quality of Life (QoL) and understand the clinical characteristics of patients in Ghana presenting with RRD compared to age-matched controls.

methodsThis prospective case-control study included patients presenting with RRD at a tertiary hospital in Ghana between July 2021 and June 2022 compared to age-matched unaffected individuals. QoL was evaluated using the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25). Demographic and clinical characteristics were analysed.

resultsAmong 180 participants (57 RRD cases, 123 controls), QoL scores ranged 50–70 for RRD patients and 60–90 for controls. The overall composite score of NEI-VFQ-25 in the RRD patients (mean 61; SD 12) was significantly lower than that of controls (mean 78; SD 15), including 8 of 12 QoL subscales (p < 0.001). The lowest subscale scores for RRD cases were vision-specific role difficulties (mean 48; SD 8). Floaters were the most common presenting symptom among RRD cases (75.4% vs. 1.6%) (p < 0.001). RDD patients presented to a primary eye centre after an average 30.8 days (SD = 70.0) and to a tertiary centre after 200.4 days (SD = 306.8).

conclusionThere is a significant reduction in the QoL for RRD patients. Early diagnosis and management of RRD are essential to mitigate the adverse impact on QoL and prevent further complications.

Indexed as

Quality of LifeRetinal DetachmentAdultAgedCase-Control StudiesFemaleGhanaHumansMaleMiddle AgedProspective StudiesSurveys and QuestionnairesTertiary Care CentersVisual AcuityYoung AdultGlobal burden of diseaseIrreversible blindnessPrimary carePublic healthQuality of lifeRhegmatogenous retinal detachmentSub-Saharan AfricaTreatment delay

Identifiers

PMID41055810
PMCPMC12504154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.